ATE168006T1 - Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung - Google Patents

Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung

Info

Publication number: ATE168006T1
Authority: AT; Austria
Prior art keywords: medical use; new medical; pharmaceutical preparation; pct; preparation containing
Prior art date: 1990-10-12

Application number

AT91917473T

Other languages

English (en)

Inventor

Alison Jane Pilgrim

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-12

Filing date

1991-10-11

Publication date

1998-07-15

1991-10-11 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1998-07-15 Application granted granted Critical

1998-07-15 Publication of ATE168006T1 publication Critical patent/ATE168006T1/de

Links

SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
208000008548 Tension-Type Headache Diseases 0.000 abstract 2
206010043269 Tension headache Diseases 0.000 abstract 1
231100000869 headache Toxicity 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical compound CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pain & Pain Management (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

AT91917473T 1990-10-12 1991-10-11 Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung ATE168006T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909022250A GB9022250D0 (en)	1990-10-12	1990-10-12	Medicaments

Publications (1)

Publication Number	Publication Date
ATE168006T1 true ATE168006T1 (de)	1998-07-15

Family

ID=10683660

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91917473T ATE168006T1 (de)	1990-10-12	1991-10-11	Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung

Country Status (16)

Country	Link
US (1)	US5376672A (de)
EP (1)	EP0552205B1 (de)
JP (1)	JP3159263B2 (de)
KR (1)	KR0178762B1 (de)
AT (1)	ATE168006T1 (de)
AU (1)	AU660153B2 (de)
CA (1)	CA2093527A1 (de)
DE (1)	DE69129750T2 (de)
DK (1)	DK0552205T3 (de)
ES (1)	ES2118090T3 (de)
GB (1)	GB9022250D0 (de)
IE (1)	IE913580A1 (de)
IL (1)	IL99715A (de)
TW (1)	TW212756B (de)
WO (1)	WO1992006688A1 (de)
ZA (1)	ZA918117B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69434535T2 (de) *	1993-12-28	2006-07-20	Allergan, Inc., Irvine	Toxische Komponente der Botulinumtoxine zur Modulation cholinergisch kontrollierter Sekretionen
RU2180852C2 (ru) *	1994-12-12	2002-03-27	Омерос Медикл Системс, Инк.	Ингибирующий раствор и способ подавления боли, воспаления или спазма
US20040068000A1 (en) *	2002-10-02	2004-04-08	Mintong Guo	Compression coated tablets
US20080213363A1 (en) *	2003-01-23	2008-09-04	Singh Nikhilesh N	Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
US20060002989A1 (en) *	2004-06-10	2006-01-05	Ahmed Salah U	Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
US8653066B2 (en)	2006-10-09	2014-02-18	Charleston Laboratories, Inc.	Pharmaceutical compositions
EP2240022B1 (de)	2008-01-09	2016-12-28	Charleston Laboratories, Inc.	Oxycodone und Promethazine enthaltende zweischichtige Tabletten
US8304179B2 (en) *	2009-05-11	2012-11-06	Taiwan Semiconductor Manufacturing Company, Ltd.	Method for manufacturing a semiconductor device using a modified photosensitive layer
US20100287502A1 (en) *	2009-05-11	2010-11-11	Olympus Imaging Corp.	Image search device and image search method
EP2451274B1 (de)	2009-07-08	2017-10-04	Charleston Laboratories, Inc.	Pharmazeutische zusammensetzungen
US10179109B2 (en)	2016-03-04	2019-01-15	Charleston Laboratories, Inc.	Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZW19381A1 (en) *	1980-08-12	1983-03-09	Glaxo Group Ltd	Heterocyclic compounds
GR79215B (de) *	1982-06-07	1984-10-22	Glaxo Group Ltd
GB8332437D0 (en) *	1983-12-06	1984-01-11	Glaxo Group Ltd	Chemical compounds
GB2162522B (en) *	1984-08-01	1988-02-24	Glaxo Group Ltd	An indole derivative
GB8419575D0 (en) *	1984-08-01	1984-09-05	Glaxo Group Ltd	Chemical compounds

1990
- 1990-10-12 GB GB909022250A patent/GB9022250D0/en active Pending
1991
- 1991-10-11 AT AT91917473T patent/ATE168006T1/de not_active IP Right Cessation
- 1991-10-11 AU AU86422/91A patent/AU660153B2/en not_active Ceased
- 1991-10-11 US US08/030,387 patent/US5376672A/en not_active Expired - Lifetime
- 1991-10-11 EP EP91917473A patent/EP0552205B1/de not_active Expired - Lifetime
- 1991-10-11 KR KR1019930701093A patent/KR0178762B1/ko not_active Expired - Fee Related
- 1991-10-11 DK DK91917473T patent/DK0552205T3/da active
- 1991-10-11 JP JP51611991A patent/JP3159263B2/ja not_active Expired - Fee Related
- 1991-10-11 ES ES91917473T patent/ES2118090T3/es not_active Expired - Lifetime
- 1991-10-11 ZA ZA918117A patent/ZA918117B/xx unknown
- 1991-10-11 CA CA002093527A patent/CA2093527A1/en not_active Abandoned
- 1991-10-11 DE DE69129750T patent/DE69129750T2/de not_active Expired - Fee Related
- 1991-10-11 WO PCT/GB1991/001768 patent/WO1992006688A1/en not_active Ceased
- 1991-10-11 IL IL9971591A patent/IL99715A/en not_active IP Right Cessation
- 1991-10-16 IE IE358091A patent/IE913580A1/en not_active Application Discontinuation
- 1991-11-22 TW TW080109170A patent/TW212756B/zh active

Also Published As

Publication number	Publication date
EP0552205B1 (de)	1998-07-08
JP3159263B2 (ja)	2001-04-23
ZA918117B (en)	1992-08-26
EP0552205A1 (de)	1993-07-28
IE913580A1 (en)	1992-04-22
KR0178762B1 (ko)	1999-03-20
US5376672A (en)	1994-12-27
IL99715A0 (en)	1992-08-18
DE69129750T2 (de)	1998-11-12
DE69129750D1 (de)	1998-08-13
GB9022250D0 (en)	1990-11-28
TW212756B (de)	1993-09-11
IL99715A (en)	1996-01-19
JPH06501935A (ja)	1994-03-03
ES2118090T3 (es)	1998-09-16
DK0552205T3 (da)	1999-04-19
WO1992006688A1 (en)	1992-04-30
AU660153B2 (en)	1995-06-15
CA2093527A1 (en)	1992-04-13
AU8642291A (en)	1992-05-20

Similar Documents

Publication	Publication Date	Title
TR199902253T2 (xx)	1999-12-21	�n g�z odac��nda farmas�tik maddelerin kontroll� sal�n�m�.
DE69432076D1 (de)	2003-03-06	Neue pharmazeutische formulierungen
IT1202558B (it)	1989-02-09	Protesi interna per la sostituzione di una parte del corpo umano particolarmente nelle operazioni vascolari
CO4340681A1 (es)	1996-07-30	Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
BR9508655A (pt)	1997-08-12	Composição farmacêutica aquosa estéril
DE69129750D1 (de)	1998-08-13	Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung
ID28003A (id)	2001-05-03	Turunan-turunan adamantana
IT1274879B (it)	1997-07-25	Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
DE69721766D1 (de)	2003-06-12	Neue arzneiformulierung
EE9700286A (et)	1998-06-15	Miootiliste ja müdriaatiliste ravimite kontrollitav vabanemine silma eeskambris
ATE141792T1 (de)	1996-09-15	Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson- syndromen
AU3078892A (en)	1993-06-28	Human interleukin-8 analogs
ATE213633T1 (de)	2002-03-15	Lamotrigin haltiges arzneimittel
SE9402880D0 (sv)	1994-08-30	New peptide derivatives
IL127044A (en)	2001-03-19	Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenertive diseases
EE03385B1 (et)	2001-04-16	Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
GR3030032T3 (en)	1999-07-30	Human il-3 variants.
HUT76796A (en)	1997-11-28	Use of 2,4-diamino pyrimidine 3-oxide or salts thereof for preparing pharmaceutical composition for treating collagen maturation and structruring disorders
CL2002001701A1 (es)	2010-06-25	Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.
SE8901149D0 (sv)	1989-04-03	Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
GR3024854T3 (en)	1998-01-30	Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
DE69616591D1 (de)	2001-12-06	Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
SE9604752D0 (sv)	1996-12-20	Formulation and use
ATE168681T1 (de)	1998-08-15	3-phenylureido-1,5-benzodiazepin-dione verwendbar als gastrin- oder cck antagonisten
NO952912D0 (no)	1995-07-21	En ny osteoblastisk proliferativ faktor

Legal Events

Date	Code	Title	Description
1999-01-15	UEP	Publication of translation of european patent specification
2003-07-15	REN	Ceased due to non-payment of the annual fee